Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-061843

Chief Medical Officer sold 6,890 shares at an average $20.01 ($137,835)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2019-12-19 Sale −2,566 $20.00 $51,320 4,324 D
Ho Carole Chief Medical Officer 2019-12-20 Sale −860 $20.00 $17,200 3,464 D
Ho Carole Chief Medical Officer 2019-12-23 Sale −3,464 $20.01 $69,315 0 D
Open-market sales · 6,890 sh · avg $20.01 · $137,835
Loading xslF345X03/doc4.xml…